Published in J Child Adolesc Psychopharmacol on April 01, 2005
Association of suicide and antidepressant prescription rates in Japan, 1999-2003. J Clin Psychiatry (2007) 0.93
Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents. Psychopharmacology (Berl) (2006) 0.92
A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology (Berl) (2010) 0.88
Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder. Eur Child Adolesc Psychiatry (2008) 0.84
Reboxetine use in the treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2006) 0.77
Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders. Iran J Psychiatry (2013) 0.77
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 5.15
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry (2009) 2.74
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry (2014) 2.15
Musical hallucinations: prevalence in psychotic and nonpsychotic outpatients. J Clin Psychiatry (2004) 1.70
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab (2006) 1.69
Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry (2004) 1.55
Effect of implementing dental services in Israeli psychiatric hospitals on the oral and dental health of inpatients. Psychiatr Serv (2009) 1.51
Itching in the psychiatric ward. Acta Derm Venereol (2008) 1.43
Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry (2006) 1.43
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome. J Clin Psychopharmacol (2002) 1.40
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Am J Psychiatry (2003) 1.24
The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol (2005) 1.24
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr (2002) 1.24
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry (2002) 1.21
Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet (2004) 1.20
Effects of climate on admission rates of schizophrenia patients to psychiatric hospitals. Eur Psychiatry (2005) 1.19
Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci (2005) 1.19
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs (2004) 1.16
An integrative quantitative model of factors influencing the course of anorexia nervosa over time. Int J Eat Disord (2009) 1.15
Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry (2013) 1.10
Fear thou not: activity of frontal and temporal circuits in moments of real-life courage. Neuron (2010) 1.09
Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol (2006) 1.09
Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Isr J Psychiatry Relat Sci (2007) 1.07
Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol (2004) 1.05
Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol (2005) 1.05
Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. J Clin Psychiatry (2003) 1.05
Cancer in schizophrenia: is the risk higher or lower? Schizophr Res (2005) 1.05
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study. Int Clin Psychopharmacol (2006) 1.04
Heart rate variability in patients with major depression. Psychosomatics (2004) 1.04
Differences in audiovisual integration, as measured by McGurk phenomenon, among adult and adolescent patients with schizophrenia and age-matched healthy control groups. Compr Psychiatry (2008) 1.02
Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study. Eur Neuropsychopharmacol (2007) 1.02
Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. Am J Psychiatry (2002) 1.01
Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. Int J Neuropsychopharmacol (2007) 1.00
Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J (2008) 1.00
Obstetric complications in individuals diagnosed with autism and in healthy controls. Compr Psychiatry (2005) 1.00
The impact of mental illness on sexual dysfunction. Adv Psychosom Med (2008) 1.00
Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol (2008) 1.00
Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. J Mol Neurosci (2004) 0.99
The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci (2011) 0.99
Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years. Schizophr Bull (2005) 0.99
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry (2006) 0.98
Alterations in QT dispersion in the surface electrocardiogram of female adolescent inpatients diagnosed with bulimia nervosa. Compr Psychiatry (2009) 0.98
Impaired procedural learning in obsessive-compulsive disorder and Parkinson's disease, but not in major depressive disorder. Behav Brain Res (2005) 0.98
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci (2007) 0.97
Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr Res (2009) 0.97
Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep (2006) 0.96
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet (2013) 0.96
The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol (2005) 0.95
Does a clerkship in psychiatry contribute to changing medical students' attitudes towards psychiatry? Acad Psychiatry (2008) 0.95
Memantine for treatment-resistant OCD. Am J Psychiatry (2005) 0.95
Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol Sci (2003) 0.95
Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol (2007) 0.95
Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry (2011) 0.95
Nicotine dependence, abuse and craving: dimensionality in an Israeli sample. Addiction (2011) 0.94
Demographic and clinical characteristics of motor vehicle accident victims in the community general health outpatient clinic: a comparison of PTSD and non-PTSD subjects. Depress Anxiety (2007) 0.94
Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry (2011) 0.94
Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol (2003) 0.93
Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med Genet (2012) 0.92
Alcohol use disorders and perceived drinking norms: ethnic differences in Israeli adults. J Stud Alcohol Drugs (2012) 0.92
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study. J Clin Psychopharmacol (2003) 0.92
The ternary complex of Pseudomonas aeruginosa alcohol dehydrogenase with NADH and ethylene glycol. Protein Sci (2004) 0.92
Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry (2010) 0.92
Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem Pharmacol (2004) 0.92
Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder? World J Biol Psychiatry (2003) 0.91
Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord (2011) 0.91
Velo-Cardio-Facial Syndrome. J Ment Health Res Intellect Disabil (2009) 0.91
Childhood adversity moderates the effect of ADH1B on risk for alcohol-related phenotypes in Jewish Israeli drinkers. Addict Biol (2013) 0.91
Familial expressed emotion: outcome and course of Israeli patients with schizophrenia. Schizophr Bull (2002) 0.91
Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry (2003) 0.90
The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study. Eur Neuropsychopharmacol (2004) 0.90
Admission rates of bipolar depressed patients increase during spring/summer and correlate with maximal environmental temperature. Bipolar Disord (2004) 0.90
Mirtazapine - a multifunctional drug: low dose for akathisia. CNS Spectr (2011) 0.90
The role of the father in child sleep disturbance: child, parent, and parent-child relationship. Infant Ment Health J (2014) 0.90
Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophr Res (2011) 0.90
Altered thermoregulation in ambulatory schizophrenia patients: a naturalistic study. World J Biol Psychiatry (2009) 0.89
An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia. Biol Psychiatry (2002) 0.89
Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry (2003) 0.88
Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Eur Neuropsychopharmacol (2003) 0.88
DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system. Neuropsychopharmacology (2008) 0.88
The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet Genomics (2008) 0.88
Enhanced cancer risk among patients with bipolar disorder. J Affect Disord (2007) 0.87
Emerging association between addictive gaming and attention-deficit/hyperactivity disorder. Curr Psychiatry Rep (2012) 0.87
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Drug Saf (2004) 0.87
Life events and suicidality in adolescents with schizophrenia. Eur Child Adolesc Psychiatry (2005) 0.87
Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophr Res (2004) 0.87
Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study. Clin Neuropharmacol (2010) 0.87
Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study. J Neural Transm (Vienna) (2009) 0.87
Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J Psychiatr Res (2003) 0.87
Two different putative genetic animal models of childhood depression. Biol Psychiatry (2005) 0.87
Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. J Clin Psychiatry (2003) 0.87
Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy. Depress Anxiety (2009) 0.86
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Psychopharmacology (Berl) (2012) 0.86
QT dispersion in patients with social phobia. J Affect Disord (2004) 0.86
The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry (2005) 0.86
Effects of long-term valproic acid treatment on hematological and biochemical parameters in adolescent psychiatric inpatients: a retrospective naturalistic study. Int Clin Psychopharmacol (2015) 0.85
Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings. Alcohol Alcohol (2007) 0.85
The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. Int J Geriatr Psychiatry (2004) 0.85
In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int J Oncol (2010) 0.85